CO2 Transmission Into Bulk Drug Substance Containers

Significance of Topic

Carbon dioxide ingress into bulk drug substance containers stored and shipped on dry ice can compromise product pH and stability. While thin-walled bag systems are known to allow CO2 permeation, rigid bottles also pose risks if container closure integrity is not assured.

Objectives and Study Overview

Two investigative studies were conducted by a biopharmaceutical company to establish the optimal closure style and torque specification for 1,000 mL Purillex® PFA bottles. The goal was to prevent CO2 ingress during a simulated 14-day dry ice shipping process.

Methods and Instrumentation

• Bottles: 1,000 mL Purillex® PFA containers.
• Formulation: buffer solution at pH 7.3; fill volumes of 100 mL (Study 1 and most of Study 2) and one 700 mL sample.
• Freezing: −80 °C cryofreezer for 48 h (Study 1) or 24 h (Study 2).
• Shipping simulation: transport box packed with dry ice pellets, replenished over a maximum of 14 days.
• Closure variants: standard one-piece GL45 and new two-piece GL45 with floating insert.
• Torque settings: 40, 45, 50, and 55 inch-pounds using a calibrated torque wrench.
• Analytical endpoint: pH measurement pre- and post-shipment (ΔpH > 0.1 indicates significant CO2 entry).

Key Results and Discussion

• Study 1: Standard closures torqued from 40 to 55 in-lb maintained pH within 0.1 units, except one outlier at 45 in-lb (pH dropped to 6.8). This prompted the design of a two-piece closure with a floating insert for consistent seal alignment.
• Study 2: The two-piece floating insert closure held pH within ±0.1 at all torque settings; a pierced positive control showed a 1.4 unit pH drop, and an overwrapped negative control matched test bottles, confirming the closure’s effectiveness.

Benefits and Practical Applications

• Fluoropolymer PFA bottles sustain structural integrity during freezing and maintain reliable sidewall barrier properties.
• Validated torque values and enhanced two-piece closures ensure container closure integrity (CCI) for prolonged dry ice shipping.
• Implementation supports QA/QC, stability of bulk drug substances, and operational efficiency in pharmaceutical cold-chain logistics.

Future Trends and Potential Applications

• Development of advanced closure designs for larger vessel formats and diverse chemical formulations.
• Standardization of CCI testing protocols for cold-chain containers.
• Extension of these integrity solutions to other temperature-sensitive bioproducts and reagents.

Conclusion

The two-piece GL45 closure with a floating insert, when applied at specified torque settings, effectively prevents CO2 ingress into 1,000 mL PFA bottles during 14 days of dry ice shipping. Adoption of this closure system enhances pH stability and ensures product integrity for bulk drug substance transport.